Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Clinical Immunology and Immunopathology|June 6, 1998
Prognostic value of MIP-1 alpha, TGF-beta 2, sELAM-1, and sVCAM-1 in patients with gram-positive sepsisS Knapp, F Thalhammer, G J Locker, et al.
The Journal of Trauma|May 29, 1998
Diagnostic validity of pulmonary artery catheterization for residents at an intensive care unitT Staudinger, G J Locker, K Laczika, et al.
Journal of Clinical Anesthesia|December 4, 2003
Bedside exclusion of clinically significant recirculation volume during venovenous ECMO using conventional blood gas analysesGottfried J Locker, Heidrun Losert, Peter Schellongowski, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|March 1, 1995
Polymerase chain reaction versus Southern blot hybridization. Detection of immunoglobulin heavy-chain gene rearrangementsN Sioutos, A Bagg, G Y Michaud, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 4, 2008
Catastrophic graft-versus-host disease after lung transplantation proven by PCR-based chimerism analysisNina Worel, Andja Bojic, Michael Binder, et al.
The American Journal of Pathology|October 1, 1988
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppressionM A Nalesnik, R Jaffe, T E Starzl, et al.
Anti-Cancer Drugs|June 1, 2000
Vinorelbine and interferon-alpha2c as second-line therapy in metastatic renal cell carcinomaM Schmidinger, G G Steger, A C Budinsky, et al.
Vox Sanguinis|April 26, 2006
Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin)Peter Schellongowski, Edith Bauer, Ulrike Holzinger, et al.
Oncogene|July 5, 2006
Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazoleH Huang, H Wang, M Sinz, et al.
European Cytokine Network|October 7, 2000
Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2G J Locker, J Kofler, B Stoiser, et al.
Pageof 18